SCHEMBL1134322

SCHEMBL1134322

CCCOCC1CCC(N2CCC(N3CNC[C@H]4CCCC[C@@H]43)CC2)CC1

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 4/20 0.38
OPRL1 P41146 4/20 0.38
L3MBTL3 Q96JM7 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1134421 0.91 OPRM1 (0.37) OPRM1OPRL1L3MBTL3L3MBTL1
SCHEMBL1134306 0.83 OPRM1 (0.35) OPRM1OPRL1L3MBTL3L3MBTL1
SCHEMBL4352452 0.79 OPRL1 (0.49) OPRM1OPRL1
SCHEMBL28791711 0.77 OPRM1 (0.38) OPRM1OPRL1
SCHEMBL1134266 0.72
SCHEMBL1134321 0.72 OPRM1 (0.31) OPRM1OPRL1
SCHEMBL4350703 0.70 OPRM1 (0.48) OPRM1OPRL1
SCHEMBL13622840 0.69 OPRL1 (0.45) OPRM1OPRL1
SCHEMBL27814846 0.67 OPRM1 (0.36) OPRM1OPRL1
SCHEMBL12064423 0.63 CYP1A2 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2285798-A1 MUSCARINIC RECEPTOR AGONITS USEFUL IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA AstraZeneca AB (SE) 2011-02-23 EP claimed
WO-2009136850-A1 MUSCARINIC RECEPTOR AGONITS USEFUL IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA ASTRAZENECA AB (SE) 2009-11-12 WO claimed
EP-2285798-A1 MUSCARINIC RECEPTOR AGONITS USEFUL IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA AstraZeneca AB (SE) 2011-02-23 EP disclosed
WO-2009136850-A1 MUSCARINIC RECEPTOR AGONITS USEFUL IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA ASTRAZENECA AB (SE) 2009-11-12 WO disclosed